PARP inhibitors have improved survival of breast cancer patients with BRCA1/2 mutations, but the cancer eventually returns. A Columbia study has now identified a drug that may prevent that relapse.
Including BRCA1 testing with prenatal carrier screening could identify people at risk of breast, ovarian, and pancreatic cancer at a time when cancer screening could save their lives.
Physician-scientist Neil Vasan brings the perspectives he's gained from classical singing and structural biology to his search for new breast cancer treatments.
A significantly lower proportion of Hispanic and Black women who underwent screening received 3D mammograms, according to a new study presented at the 2022 San Antonio Breast Cancer Symposium.
Columbia University's chief of breast imaging, Elise Desperito, MD, clarifies conflicting advice on mammography and urges all women to be evaluated for their breast cancer risk.
Columbia breast cancer patient Karin Diamond credits regular mammograms for catching her cancer early and her surgeon's use of intraoperative radiation for keeping her cancer-free.
Overall survival for breast cancer has improved by about 40% since the 1980s. Precision medicine and new screening tests may lead to even better outcomes in the future.
Opinions vary about how to treat DCIS (ductal carcinoma in situ), but a new study suggests the optimal treatment for most women with this non-invasive breast cancer is surgery plus radiation.
Columbia's Eileen Connolly explains how radiation treatment for breast cancer has vastly improved in recent years due to advancements in technology and an increased understanding of the disease.
Breast cancer survival has improved by about 40% since the 1980s. Columbia oncologist Katherine Crew discusses how new genetic tests, treatments, and screening methods should further improve survival.